Nonalcoholic Fatty Liver Disease: Pathogenesis and Therapeutics from a Mitochondria-Centric Perspective
Nonalcoholic fatty liver disease (NAFLD) describes a spectrum of disorders characterized by the accumulation of triglycerides within the liver. The global prevalence of NAFLD has been increasing as the obesity epidemic shows no sign of relenting. Mitochondria play a central role in hepatic lipid met...
Main Authors: | Aaron M. Gusdon, Ke-xiu Song, Shen Qu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2014/637027 |
Similar Items
-
Role of Mitochondria in Nonalcoholic Fatty Liver Disease
by: Fatiha Nassir, et al.
Published: (2014-05-01) -
Mitochondrial haplogroup G is associated with nonalcoholic fatty liver disease, while haplogroup A mitigates the effects of PNPLA3
by: Aaron M. Gusdon, et al.
Published: (2021-01-01) -
Micronutrients in Nonalcoholic Fatty Liver Disease PathogenesisSummary
by: Octavia Pickett-Blakely, et al.
Published: (2018-01-01) -
Research advances in the pathogenesis of nonalcoholic fatty liver disease
by: WANG Hu, et al.
Published: (2017-04-01) -
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
by: Agostino Di Ciaula, et al.
Published: (2021-05-01)